Rexulti tablets 1mg from Otsuka Pharmaceutical contains brexpiprazole, an atypical antipsychotic used as an adjunctive therapy for major depressive disorder and for the treatment of schizophrenia, and agitation associated with dementia due to Alzheimer’s disease. The YJ code is 1179058F1020, with a standard of 1mg per tablet.
Rexulti tablets 1mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
